Cancer cell CD73 loss promotes a dual inflammatory and immunosuppressive microenvironment in endometrial carcinoma.
CD73 is an emerging immunotherapy target that is overexpressed in many tumors and generates an adenosine-rich microenvironment to suppress antitumor immunity. In low-grade endometrial carcinoma (EC), CD73 expression varies, and its impact on tumor immunobiology is unknown. Using two microsatellite-stable, grade 2 endom...